Back to News >

A leading Greek pharmaceutical company began its activities in 1974.

The company aims to provide high quality medicines at affordable prices.

The company offers more than 150 different pharmaceutical products.

It has an expanding presence in the domestic and international market.

The company’s annual investments in research represent approximately 7% of the turnover.

As a result, the company has established partnerships with leading companies in Europe and all over the world. Today the company has more than 500 employees.

The company is interested in establishing business collaboration with manufacturers of generic pharmaceutical products for the following medicinal products:

• Leuprorelin
• Triptorelin

The Greek company would like to conduct a distribution agreement with the producer of the mentioned medicinal products, for the Greek market.

Specifications:

The Greek pharmaceutical company is interested in products with available EU CTD (Common Technical Document). Products under development could be also considered.

Collaboration sought:

The Greek company is looking for pharmaceutical companies, producers of generics of Leuprorelin and Triptorelin. The Greek company would like to conclude a distribution agreement, under licencing, for the distribution of the mentioned pharmaceutical products in Greece.

Contact Claire Robinson for more information at claire.robinson@rtcnorth.co.uk